Two Sigma Investments’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148K | Buy |
72,727
+363
| +0.5% | +$739 | ﹤0.01% | 2910 |
|
|
2025
Q1 | $118K | Buy |
+72,364
| New | +$118K | ﹤0.01% | 2884 |
|
|
2024
Q4 | – | Sell |
-23,195
| Closed | -$134K | – | 3270 |
|
|
2024
Q3 | $134K | Sell |
23,195
-14,403
| -38% | -$83.2K | ﹤0.01% | 2790 |
|
|
2024
Q2 | $304K | Buy |
37,598
+17,337
| +86% | +$140K | ﹤0.01% | 2512 |
|
|
2024
Q1 | $281K | Sell |
20,261
-7,163
| -26% | -$99.4K | ﹤0.01% | 2516 |
|
|
2023
Q4 | $168K | Sell |
27,424
-41,679
| -60% | -$255K | ﹤0.01% | 2789 |
|
|
2023
Q3 | $323K | Sell |
69,103
-80,750
| -54% | -$377K | ﹤0.01% | 2389 |
|
|
2023
Q2 | $803K | Buy |
+149,853
| New | +$803K | ﹤0.01% | 2003 |
|
|
2023
Q1 | – | Sell |
-35,210
| Closed | -$659K | – | 2998 |
|
|
2022
Q4 | $659K | Sell |
35,210
-122,990
| -78% | -$2.3M | ﹤0.01% | 1846 |
|
|
2022
Q3 | $3.28M | Sell |
158,200
-223,436
| -59% | -$4.63M | 0.01% | 907 |
|
|
2022
Q2 | $7.92M | Buy |
381,636
+186,768
| +96% | +$3.88M | 0.03% | 568 |
|
|
2022
Q1 | $8.4M | Buy |
+194,868
| New | +$8.4M | 0.02% | 660 |
|
|
2020
Q1 | – | Sell |
-12,751
| Closed | -$505K | – | 2154 |
|
|
2019
Q4 | $505K | Buy |
12,751
+11,366
| +821% | +$450K | ﹤0.01% | 1698 |
|
|
2019
Q3 | $34K | Sell |
1,385
-8,730
| -86% | -$214K | ﹤0.01% | 1885 |
|
|
2019
Q2 | $357K | Sell |
10,115
-1,082
| -10% | -$38.2K | ﹤0.01% | 1695 |
|
|
2019
Q1 | $501K | Sell |
11,197
-3,391
| -23% | -$152K | ﹤0.01% | 1651 |
|
|
2018
Q4 | $700K | Buy |
14,588
+2,048
| +16% | +$98.3K | ﹤0.01% | 1460 |
|
|
2018
Q3 | $837K | Buy |
12,540
+10,446
| +499% | +$697K | ﹤0.01% | 1439 |
|
|
2018
Q2 | $98K | Buy |
+2,094
| New | +$98K | ﹤0.01% | 1942 |
|